3//SEC Filing
Sarissa Capital Master Fund II LP 3
Accession 0001567619-20-020223
CIK 0001659323other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 5:01 PM ET
Size
19.5 KB
Accession
0001567619-20-020223
Insider Transaction Report
Form 3
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Denner Alexander J
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Sarissa Capital Catapult Fund LLC
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Sarissa Capital Management LP
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Sarissa Capital Hawkeye Fund LP
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Sarissa Capital Master Fund II LP
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Footnotes (4)
- [F1]See Exhibit 99.1
- [F2]See Exhibit 99.1
- [F3]See Exhibit 99.1
- [F4]See Exhibit 99.1
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001811636
Filing Metadata
- Form type
- 3
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 5:01 PM ET
- Size
- 19.5 KB